Lindeman Asia Investment Co. Ltd (277070) - Total Liabilities

Latest as of September 2025: ₩7.36 Billion KRW ≈ $4.99 Million USD

Based on the latest financial reports, Lindeman Asia Investment Co. Ltd (277070) has total liabilities worth ₩7.36 Billion KRW (≈ $4.99 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Lindeman Asia Investment Co. Ltd - Total Liabilities Trend (2015–2024)

This chart illustrates how Lindeman Asia Investment Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. See how liquid is Lindeman Asia Investment Co. Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.

Lindeman Asia Investment Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Lindeman Asia Investment Co. Ltd ranked by their total liabilities.

Company Country Total Liabilities
Deliveroo Holdings PLC
LSE:ROO
UK GBX580.90 Million
SBH Marine Holdings Berhad
KLSE:0300
Malaysia RM18.50 Million
Khee San Bhd
KLSE:6203
Malaysia RM150.57 Million
MPC Energy Solutions NV
OL:MPCES
Norway Nkr79.42 Million
Allianz Technology Trust PLC
LSE:ATT
UK GBX1.77 Million
Jiangsu Youli Investment Holding Co Ltd
SHE:000584
China CN¥3.19 Billion
Hae In
KO:003010
Korea ₩123.03 Billion
Level Biotechnology
TWO:3118
Taiwan NT$237.03 Million

Liability Composition Analysis (2015–2024)

This chart breaks down Lindeman Asia Investment Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Lindeman Asia Investment Co. Ltd (277070) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 41.82 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.12 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.11 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Lindeman Asia Investment Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Lindeman Asia Investment Co. Ltd (2015–2024)

The table below shows the annual total liabilities of Lindeman Asia Investment Co. Ltd from 2015 to 2024.

Year Total Liabilities Change
2024-12-31 ₩10.77 Billion
≈ $7.30 Million
+3.48%
2023-12-31 ₩10.41 Billion
≈ $7.05 Million
-9.75%
2022-12-31 ₩11.53 Billion
≈ $7.82 Million
+4.21%
2021-12-31 ₩11.07 Billion
≈ $7.50 Million
-33.79%
2020-12-31 ₩16.71 Billion
≈ $11.33 Million
+112.30%
2019-12-31 ₩7.87 Billion
≈ $5.33 Million
+125.47%
2018-12-31 ₩3.49 Billion
≈ $2.37 Million
+117.16%
2017-12-31 ₩1.61 Billion
≈ $1.09 Million
-9.14%
2016-12-31 ₩1.77 Billion
≈ $1.20 Million
+12.21%
2015-12-31 ₩1.58 Billion
≈ $1.07 Million
--

About Lindeman Asia Investment Co. Ltd

KQ:277070 Korea Investment Banking & Investment Services
Market Cap
$32.30 Million
₩47.66 Billion KRW
Market Cap Rank
#23556 Global
#1594 in Korea
Share Price
₩3530.00
Change (1 day)
-2.62%
52-Week Range
₩3470.00 - ₩5860.00
All Time High
₩15852.08
About

Lindeman Asia Investment Co., Ltd. is a venture capital and private equity firm specializing in small and medium sized venture companies, equity, mezzanine, 1st, 2nd and 3rd round investments. The firm primarily makes investments in pre-IPO, middle market companies and emerging growth, operating in the bio and healthcare, chemistry and material, game and contents, ICT manufacturing, ICT service, … Read more